WHO ICTRP trial
Effect of Esketamine Supplementation on Propofol Requirements During…
ChiCTR2500104602 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500104602 |
|---|---|
| Public title | Effect of Esketamine Supplementation on Propofol Requirements During Hysteroscopy |
| Scientific title | Effect of Esketamine Supplementation on Propofol Requirements During Hysteroscopy |
| Primary sponsor | Women and Children’s Hospital of Ningbo University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Interventions | 0.4mg/kg Esketamine Group:Esketamine;0.1 mg/kg Esketamine Group:Esketamine;0.2 mg/kg Esketamine Group:Esketamine;0.3mg/kg Esketamine Group:Esketamine;0 mg/kg Esketamine Group:Esketamine |
| Registration date | Jun 19, 2025 |
| Target size | 0.4mg/kg Esketamine Group:30;0.1 mg/kg Esketamine Group:30;0.2 mg/kg Esketamine… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: